Skip to main content
SpringerLink
Log in

Interactions between a “calcium channel agonist”, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

  1. 1.

    The proposal that calcium antagonists have different sites of action has been tested by attempting to reverse their inhibitory effects with a dihydropyridine which augments Ca2+ entry into cells, Bay K 8644.

  2. 2.

    Bay K 8644 (1–1000 nmol/l) increased the sensitivity to Ca2+ of K+-depolarized taenia preparations from the guinea-pig caecum. Thus Bay K 8644 augmented established submaximal Ca2+-induced contractions and also shifted cumulative concentration-response curves to Ca2+ to the left, even in the presence of an optimal K+-depolarization.

  3. 3.

    The inhibitory effects of nifedipine (10 nmol/l), verapamil (0.2 μmol/l), diltiazem (1 μmol/l) and diclofurime (1 μmol/l) on Ca2+-induced contractions were reversed by Bay K 8644 (1–100 nmol/l). In contrast, Bay K 8644 did not reverse the effects of cinnarizine (1 μmol/l), flunzrizine (1 μmol/l), fendiline (3 μmol/l), prenylamine (3 μmol/l), pimozide (1 μmol/l), bepridil (3 μmol/l), perhexiline (10 μmol/l) or the calmodulin antagonist W-7 (200 μmol/l).

  4. 4.

    Bay K 8644 (1–100 nmol/l) was less effective at reversing the effects of nisoldipine (10 nmol/l), a slowly dissociating dihydropyridine, than the effects of nifedipine. However, preincubation with Bay K 8644 (1 μmol/l) protected the taenia from the inhibitory effects of nisoldipine (10 nmol/l). These findings are compatible with interactions of nisoldipine and Bay K 8644 at a common site.

  5. 5.

    Taenia preparations incubated with Bay K 8644 (1 μmol/l) were protected from the inhibitory effects of nifedipine (10 nmol/l), nisoldipine (10 nmol/l) and to a lesser extent verapamil (0.2 μmol/l) and diltiazem (1 μmol/l). However, there was no protection against the inhibitory effects of cinnarizine (1 μmol/l), flunarizine (1 μmol/l), pimozide (1 μmol/l), fendiline (3 μmol/l), prenylamine (3 μmol/l) or W-7 (200 μmol/l). Thus, the lack of protection indicates that there is no interaction between the dihydropyridine site and the site for the latter drugs. These experiments show that Bay K 8644 defines subgroups of calcium antagonists which are the same as those previously reported from functional studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albus U, Habermann E, Ferry DR, Glossmann H (1984) Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent (3H)noradrenaline release from PC12 cells. J Neurochem 42:1186–1189

    Google Scholar 

  • Anno T, Furuta T, Itoh M, Kodama I, Toyama J, Yamada K (1984) Electromechanical effects of bepridil on rabbit isolated hearts. Br J Pharmacol 81:41–47

    Google Scholar 

  • Arunlakshana O, Schild HO (1959) Some quantitative used of drug antagonists. Br J Pharmacol Chemother 14:48–58

    Google Scholar 

  • Bayer R, Kaufmann R, Mannhold R, Rodenkirchen R (1982) The action of specific Ca antagonists on cardiac electrical activity. Progr Pharmacol 5:53–85

    Google Scholar 

  • Bellemann P, Schade A, Towart R (1983) Dihydropyridine receptor in rat brain labelled with (3H)nimodipine. Proc Natl Acad Sci USA 80:2356–2360

    Google Scholar 

  • Bolger GT, Gengo P, Klockowski E, Luchowski E, Siegel H, Janis RA, Triggle AM, Triggle DJ (1983) Characterization of binding of the Ca2+ channel antagonist, (3H)nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther 225:291–309

    Google Scholar 

  • Bou J, Llenas J, Massingham R (1983) Calcium entry blocking drugs, “calcium antagonists” and vascular smooth muscle function. J Auton Pharmacol 3:219–232

    Google Scholar 

  • DePover A, Matlib MA, Lee SW, Dubé GP, Grupp IL, Grupp G, Schwartz A (1982) Specific binding of (3H)nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Comm 108:110–117

    Google Scholar 

  • Ehlert FJ, Itoga E, Roeske WR, Yamamura HI (1982) The interaction of (3H)nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Comm 104:937–943

    Google Scholar 

  • Ferry DR, Glossmann H (1982) Evidence for multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Arch Pharmacol 321:80–83

    Google Scholar 

  • Fleckenstein A (1981) Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes. In: Weiss GB (ed) New perspectives on calcium antagonists. Am Physiol Soc Baltimore, pp 59–81

  • Gittos M, Spedding M (1984) Comparison of cis and trans diclofurime with verapamil as calcium antagonists. Br J Pharmacol 81:81P

    Google Scholar 

  • Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F (1982) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431–437

    Google Scholar 

  • Glossmann H, Linn T, Rombusch M, Ferry DR (1983) Temperature-dependent regulation of d-cis-(3H)diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. FEBS Lett 160:226–232

    Google Scholar 

  • Godfraind T, Hardy JP, Morel N (1984) The action of the spasmogenic dihydropyridine Bay K 8644 on the mechanical and the electrical activity of guinea-pig taenia coli. Arch int Pharmacodyn Ther 268:167–168

    Google Scholar 

  • Gould RJ, Murphy KMM, Reynolds IJ, Snyder SH (1983) Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc Natl Acad Sci USA 80:5122–5125

    Google Scholar 

  • Hof RP (1984) Selective effects of different calcium antagonists on the peripheral circulation. Trends Pharmacol Sci 5:100–103

    Google Scholar 

  • Humphrey PPA, Robertson MJ (1983) Functional characteristics of verapamil and nitrendipine interactions at calcium channels in smooth muscle. Br J Pharmacol 80:502P

    Google Scholar 

  • Inomata H, Kao CY (1976) Ionic currents in the guine-pig taenia coli. J Physiol 255:347–378

    Google Scholar 

  • Johnson JD, Fugman DA (1983) Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments. J Pharmacol Exp Ther 226:330–334

    Google Scholar 

  • Karaki H, Murakami K, Nakagawa H, Ozaki H, Urakawa N (1982) Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles. Br J Pharmacol 77:661–666

    Google Scholar 

  • Kazda S, Towart R (1982) The duration of action of calcium antagonists in vitro: a comparison of nifedipine and nisoldipine (Bay K 5552). Br J Pharmacol 76:255P

  • Kazda S, Knorr A, Towart R (1983) Common properties and differences between various calcium antagonists. Progr Pharmacol 5:84–116

    Google Scholar 

  • Landry Y, Amellal M, Ruckstuhl M (1981) Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol 30:2031–2032

    Google Scholar 

  • Levin RM, Weiss GB (1979) Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activation of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther 208:454–459

    Google Scholar 

  • Lugnier C, Follenius A, Gerard D, Stoclet JC (1984) Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol 98: 157–158

    Google Scholar 

  • Marangos PJ, Patel J, Miller C, Martino AM (1982) Specific calcium antagonist binding sites in brain. Life Sci 31: 1575–1585

    Google Scholar 

  • Murphy KMM, Gould RJ, Largent BL, Snyder SH (1983) A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci USA 80:860–864

    Google Scholar 

  • Opie LH (1980) Calcium antagonists. Lancet 1:806–810

    Google Scholar 

  • Reynolds IJ, Gould RJ, Snyder SH (1983) (3H)Verapamil binding sites in brain and skeletal muscle: regulation by calcium. Eur J Pharmacol 95:315–321

    Google Scholar 

  • Riemer J, Dörfler F, Mayer C-J, Ulbrecht G (1974) Calcium antagonistic effects on the spontaneous activity of guinea-pig taenia coli. Pflüger's Arch ges Physiol 351:33–37

    Google Scholar 

  • Rodenkirchen R, Bayer R, Mannhold R (1982) Specific and non-specific Ca antagonists. A structure-activity analysis of cardiodepressive drugs. Progr Pharmacol 5:9–23

    Google Scholar 

  • Sarmiento JG, Janis RA, Maurer SC, Katz AM, Triggle DJ, Luchowski E (1983) Comparison of high affinity binding sites for Ca2+ channel inhibitors in membranes for various tissues. Is calmodulin at the binding site for Ca2+ channel inhibitors? Pharmacologist 25:202

    Google Scholar 

  • Sarmiento JG, Janis RA, Rampe D, Triggle DJ (1984) (3H) Bay K 8644, a calcium channel agonist, binds to high and low affinity sites on membranes from cardiac muscle and brain. Fed Proc 43:448

    Google Scholar 

  • Schramm M, Thomas G, Towart R, Franckowiak G (1983a) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 309:535–537

    Google Scholar 

  • Schramm M, Thomas G, Towart R, Franckowiak G (1983b) Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Arzneim-Forsch 33:1268–1272

    Google Scholar 

  • Schramm M, Towart R (1984) Modulation of calcium channel function with 1,4-dihydropyridine structure. J Physiol 349: 53P

  • Sparrow MP, Mrwa U, Hofmann F, Rüegg JC (1981) Calmodulin is essential for smooth muscle contractions. FEBS Lett 125: 141–145

    Google Scholar 

  • Spedding M (1981) Marked differences in the effects of “Ca2+ antagonists” on CaCl2-induced contractions in K+-depolarized smooth muscle. Br J Pharmacol 72:144P

    Google Scholar 

  • Spedding M (1982a) Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn-Schmiedeberg's Arch Pharmacol 318: 234–240

    Google Scholar 

  • Spedding M (1982b) Differences between the effects of calcium antagonists in the pithed rat preparation. J Cardiovasc Pharmacol 4:973–979

    Google Scholar 

  • Spedding M (1983a) Direct inhibitory effects of some “calcium antagonists” and trifluoperazine on the contractile proteins in smooth muscle. Br J Pharmacol 79:225–231

    Google Scholar 

  • Spedding M (1983b) The effects of changing surface charge with salicylate on the potency of calcium antagonists in smooth muscle. Br J Pharmacol 78:36P

    Google Scholar 

  • Spedding M (1983c) Functional interactions of calcium antagonists in K+-depolarized smooth muscle. Br J Pharmacol 80: 485–488

    Google Scholar 

  • Spedding M (1984a) Changing surface charge with salicylate differentiates between subgroups of calcium antagonists. Br J Pharmacol, in press

  • Spedding M (1984b) Calcium antagonist subgroups. Trends Pharmacol Sci: in press

  • Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol Chemother 11:379–393

    Google Scholar 

  • Towart R, Schramm M (1984) Recent advances in the pharmacology of the calcium channel. Trends Pharmacol Sci 5:111–113

    Google Scholar 

  • Triggle DJ (1984) Ca2+ channels revisited: problems and promises. Trends Pharmacol Sci 5:4–5

    Google Scholar 

  • Van Rossum JM (1963) Cumulative dose-response curves II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299–330

    Google Scholar 

  • Wadsworth RM, Moss JP (1983) Time course of the effect of flunarizine on rabbit isolated vascular muscle. Eur J Pharmacol 85:207–209

    Google Scholar 

  • Williams LT, Tremble P (1982) Binding of a calcium antagonist, (3H)nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J Clin Inv 70:209–212

    Google Scholar 

  • Yamamura HI, Schoemaker H, Boles RG, Roeske WR (1982) Diltiazem enhancement of (3H)nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Comm 108:640–646

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Merrell Dow Research Institute, Strasbourg Center, 16 rue d'Ankara, F-67084, Strasbourg Cedex, France

    Michael Spedding & Christiane Berg

Authors
  1. Michael Spedding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christiane Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spedding, M., Berg, C. Interactions between a “calcium channel agonist”, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 69–75 (1984). https://doi.org/10.1007/BF00496109

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00496109

Key words

Search

Navigation